Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CTi Biopharma Corp (NASDAQ:CTIC)

0.3339
Delayed Data
As of 3:59pm ET
 +0.014 / +4.38%
Today’s Change
0.25
Today|||52-Week Range
1.94
-72.85%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.0034.7M60.1M16.1M
 
 
 
 
Cost of Goods Sold0.00137.0K895.0K950.0K
 
 
 
 
Depreciation And Amortization2.3M1.6M1.1M990.0K
 
 
 
 
 
 
Operating ExpensesGross Income-2.3M33.0M58.1M14.2M
 
 
 
 
 
General Expenses69.1M74.3M119.7M130.6M
 
 
 
 
 
Other Operating Expenses0.000.002.7M253.0K
 
 
 
Research And Development33.2M33.6M64.6M76.6M
 
 
 
 
 
Total Operating Expenses71.4M76.0M124.5M132.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-71.4M-41.4M-64.4M-116.7M
 
 
 
 
 
Extraordinary Charge-30.1M-155.0K-21.9M-1.2M
 
 
 
 
 
Interest Expense On Debt56.0K1.5M2.7M2.5M
 
 
 
 
 
Other Expenses-134.0K-485.0K-5.3M-403.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-101.7M-43.6M-94.2M-120.8M
 
 
 
 
 
Minority Interest-313.0K-807.0K-862.0K-1.3M
 
 
 
 
 
Preferred Dividend-13.9M-6.9M-2.6M-3.2M
 
 
 
 
 
Net Income-101.4M-42.7M-93.4M-119.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS--114.2M148.5M188.4M
 
 
 
 
Shares To Calculate EPS Diluted--114.2M148.5M188.4M
 
 
 
 
 
Earnings Per ShareEPS---$0.43-$0.65-$0.65
 
 
 
 
EPS Diluted---$0.43-$0.65-$0.65